Using a genetically-optimized host, data-driven process development, and a novel manufacturing unit, Sunflower Therapeutics aims to create an efficient, patient-centered drug production platform. Their goal is to improve patient access to biological medicines worldwide by developing and manufacturing emerging technologies. The company is based in Cambridge, Massachusetts and was founded in 2018.